These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 21804393)
1. Cytokeratin 19 expression in normal endometrium and in low-grade endometrioid adenocarcinoma of the endometrium. Stewart CJ; Crook ML; Lacey J; Louwen K Int J Gynecol Pathol; 2011 Sep; 30(5):484-91. PubMed ID: 21804393 [TBL] [Abstract][Full Text] [Related]
2. Fascin expression in low-grade uterine endometrioid adenocarcinoma: correlation with microcystic, elongated and fragmented (MELF)-type alteration at the deep invasive margin. Stewart CJ; Crook ML; Manso L Histopathology; 2011 Jul; 59(1):73-80. PubMed ID: 21771028 [TBL] [Abstract][Full Text] [Related]
3. Galectin-3 expression in uterine endometrioid adenocarcinoma: comparison of staining in conventional tumor glands and in areas of MELF pattern myometrial invasion. Stewart CJ; Crook ML Int J Gynecol Pathol; 2010 Nov; 29(6):555-61. PubMed ID: 20881856 [TBL] [Abstract][Full Text] [Related]
4. CD147 (EMMPRIN) and matrix metalloproteinase-2 expression in uterine endometrioid adenocarcinoma. Stewart CJ; Crook ML Pathol Res Pract; 2011 Jan; 207(1):30-6. PubMed ID: 21144675 [TBL] [Abstract][Full Text] [Related]
5. Micro-anatomical variation in cellular proliferation in endometrial adenocarcinoma, and inverse correlation between Ki67 and cytokeratin 7 expression. Stewart CJ; Crook ML; Doherty DA Histopathology; 2010 Jul; 57(1):46-54. PubMed ID: 20557372 [TBL] [Abstract][Full Text] [Related]
6. The use of an immunocytochemical double-labeling staining can display the distribution of Bcl-2/Ki-67 cells in endometrial adenocarcinomas as well as in normal endometrium. Mourtzikou A; Kosmas K; Marouga A; Stamouli M; Pouliakis A; Karakitsos P Clin Lab; 2012; 58(1-2):133-44. PubMed ID: 22372356 [TBL] [Abstract][Full Text] [Related]
7. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance. Murray SK; Young RH; Scully RE Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811 [TBL] [Abstract][Full Text] [Related]
8. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1. Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066 [TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial-mesenchymal transition. Stewart CJ; Little L Histopathology; 2009 Jul; 55(1):91-101. PubMed ID: 19614771 [TBL] [Abstract][Full Text] [Related]
10. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium. Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909 [TBL] [Abstract][Full Text] [Related]
11. Expression of maspin in endometrioid adenocarcinoma of endometrium. Li HW; Leung SW; Chan CS; Yu MM; Wong YF Oncol Rep; 2007 Feb; 17(2):393-8. PubMed ID: 17203179 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium. Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959 [TBL] [Abstract][Full Text] [Related]
13. Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues. Brustmann H; Naudé S Pathol Res Pract; 1999; 195(12):829-34. PubMed ID: 10631718 [TBL] [Abstract][Full Text] [Related]
14. Lymphovascular space invasion in microcystic elongated and fragmented (MELF)-pattern well-differentiated endometrioid adenocarcinoma is associated with a higher rate of lymph node metastasis. Hertel JD; Huettner PC; Pfeifer JD Int J Gynecol Pathol; 2014 Mar; 33(2):127-34. PubMed ID: 24487466 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression. Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420 [TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group. Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996 [TBL] [Abstract][Full Text] [Related]
17. The selective expression of ret finger protein in endometrial cancer: can RFP be a marker of serous carcinomas? Tezel GG; Ordulu Z; Hımmetoğlu C; Usubütün A Turk Patoloji Derg; 2012; 28(3):213-9. PubMed ID: 23011823 [TBL] [Abstract][Full Text] [Related]
18. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases. Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034 [TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of heat shock protein 70, 90 in endometrial carcinomas]. Bai XX; Chen YQ; Xin XY; Wang WD Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):38-40. PubMed ID: 15132902 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical profiling of cytokeratin expression by endometrial stroma sarcoma. Adegboyega PA; Qiu S Hum Pathol; 2008 Oct; 39(10):1459-64. PubMed ID: 18619644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]